Sermonix Pharmaceuticals Inc.
2 clinical trials · Sponsor
◉ Watch Sermonix Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation (NCT04432454) | Sermonix Pharmaceuticals Inc. | 2020-09-29 |
| Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation (NCT03781063) | Sermonix Pharmaceuticals Inc. | 2019-09-20 |
Track Sermonix Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.